Impaired antibody responses to heterologous ChAdOx1 nCoV-19 and BNT162b2 vaccination in individuals with type 2 diabetes.

Comirnaty (tozinameran) - Pfizer, BioNTech

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/41107384

Chidchamai Kewcharoenwong; Ganjana Lertmemongkolchai; Phonnipha Saythanu; Sopita Sopila; Sudarat Kingpha; Wipawee Saenwongsa

Oct 18, 2025